Pure Global
NCT05848661

Evaluation of a Digital Therapy of Auditory Training

AUDISSEE-Evaluation of a New Digital Therapy of a Cognitive Auditory Training
Humans Matter·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hearing Loss, Age-Related
Drug/Device/Intervention
AUDISSEE
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Humans Matter
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
Mar 01, 2025
Enrollment
240 participants
Primary outcome

Hearing in noise,Hearing in noise,Hearing in noise,Hearing in noise,Hearing in noise,Hearing in noise,Hearing in noise,Hearing in noise

Summary

The aim of the study is to evaluate the efficiency of the medical device AUDISSEE in
 improving the perception in noise ability of presbycusis patients with hearing-aids.

ICD-10 classifications
Other hearing lossHearing loss, unspecifiedOther specified hearing lossOtotoxic hearing lossSudden idiopathic hearing loss
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05848661
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05848661 through Pure Global AI's free database. This phase not specified trial is sponsored by Humans Matter and is currently Not yet recruiting. The study focuses on Hearing Loss, Age-Related. Target enrollment is 240 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.